Initial Treatment of Differentiated Thyroid Carcinoma

被引：14

作者：

Haugen B.R. ^{[1
,2
]}

机构：

[1] Univ. of Colorado Hlth. Sci. Center, Denver, CO

[2] Univ. of Colorado Hlth. Sci. Center, B151, Denver, CO 80262

来源：

Reviews in Endocrine and Metabolic Disorders | 2000年 / 1卷 / 3期

关键词：

Differentiated thyroid carcinoma treatment; Levothyroxine therapy; Radioiodine; Staging; Thyroid carcinoma;

D O I：

10.1023/A:1010066728437

中图分类号：

学科分类号：

摘要：

Many large, retrospective studies have been performed and form the basis for how we define risk groups of patients with differentiated thyroid carcinoma and how the three basic therapeutic modalities (surgery, radioiodine and levothyroxine) affect two primary outcomes disease recurrence and death. In this review, we have hopefully distilled much of that information into a proposed current therapeutic approach to individual patients with differentiated thyroid cancer.

引用

页码：139 / 145

页数：6

共 37 条

[1]

Dulgeroff A.J., Hershamn J.M., Medical therapy for differentiated thyroid carcinoma, Endocrine Reviews, 15, pp. 500-515, (1994)

[2]

Sherman S.I., Brierley J., Sperling M., Et al., Prospective multicenter study of thyroid carcinoma treatment, Cancer, 83, pp. 1012-1021, (1998)

[3]

Brierley J.D., Panzarella T., Tsang R.W., Gospodarowicz M.K., O'Sullivan B., A comparison of different staging systems predictability of patient outcome, Cancer, 79, pp. 2414-2423, (1997)

[4]

Samaan N.A., Maheshwari Y.K., Nader S., Et al., Impact of therapy for differentiated carcinoma of the thyroid: An analysis of 706 cases, Journal of Clinical Endocrinology and Metabolism, 56, pp. 1131-1138, (1983)

[5]

Tubiana M., Schlumberger M., Rougier P., Et al., Long-term results and prognostic factors in patients with differentiated thyroid carcinoma, Cancer, 55, pp. 794-804, (1985)

[6]

Simpson W.J., McKinney S.E., Carruthers J.S., Gospodarowicz M.K., Sutcliffe S.B., Panzarella T., Papillary and follicular thyroid cancer, American Journal of Medicine, pp. 479-488, (1987)

[7]

DeGroot L.J., Kaplan E.L., McCormick M., Straus F.H., Natural history, treatment, and course of papillary thyroid carcinoma, Journal of Clinical Endocrinology and Metabolism, 71, pp. 414-424, (1990)

[8]

Samaan N.A., Schultz P.N., Hickey R.C., Et al., The results of various modalities of treatment of well differentiated thyroid carcinoma: A retrospective review of 1599 patients, Journal of Clinical Endocrinology and Metabolism, 75, pp. 714-720, (1992)

[9]

Mazzaferri E.L., Jhiang S.M., Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer, American Journal of Medicine, 97, pp. 418-428, (1994)

[10]

Tsang R.W., Brierley J., Simpson W.J., Panzarella T., Gospodarowicz M.K., Sutcliffe S.B., The effects of surgery, radioiodein, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma, Cancer, 82, pp. 375-388, (1998)

← 1 2 3 4 →